Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05294198
Other study ID # PX086
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 10, 2021
Est. completion date November 12, 2021

Study information

Verified date March 2022
Source University of Pernambuco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is no evidence that beetroot extract (Beta vulgaris L.) is advantageous for the recovery of cardiovascular parameters and the autonomic nervous system (ANS) after submaximal aerobic exercise. The objective of this study is to evaluate the effect of beetroot extract supplementation on the recovery of cardiorespiratory and autonomic parameters after a submaximal aerobic exercise session. Healthy male adults will perform a cross-over, randomized, double-blind, and placebo-controlled trial. Beetroot extract (600mg) or placebo (600mg) will be ingested 90 minutes before evaluation in randomized days. Systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), mean arterial pressure (MAP), heart rate (HR), and HR variability (HRV) indexes will be recorded at Rest and during 60 minutes of recovery from exercise.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date November 12, 2021
Est. primary completion date November 12, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Healthy males; - Physically active according to International Physical Activity Questionnaire (IPAQ); - 18 to 30 old years. Exclusion Criteria: - Body mass index BMI <18.5kg/m² and >29.9kg/m²; - Smokers; - Subjects undergoing pharmacotherapies; - Musculoskeletal, metabolic, renal diseases; - Root mean squared standard deviation of R-R intervals <15 milliseconds.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Beetroot extract
Beetroot extract capsule

Locations

Country Name City State
Brazil University of Pernambuco Petrolina Pernambuco

Sponsors (1)

Lead Sponsor Collaborator
University of Pernambuco

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Heart rate variability values (milliseconds) Through study completion, an average of 1 year
Secondary Systolic and diastolic blood pressure values (mmHg) Through study completion, an average of 1 year
Secondary Heart rate values (beats per minute) Through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04234594 - Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. Phase 1
Completed NCT01367561 - Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function Phase 1
Completed NCT00777543 - Increasing Ferulic Acid Bioavailability in Bran N/A
Recruiting NCT04756635 - Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity N/A
Completed NCT02156661 - Oxytocin and Emotion Processing Phase 1
Completed NCT01848665 - The Influence of Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Passive Heat Stress Phase 4
Completed NCT00839319 - HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone Phase 1/Phase 2
Completed NCT00842751 - Oral T7 Oral Testosterone in Man Phase 2
Completed NCT01847053 - Bioavailability Study of Cinnamon in Healthy Subjects Phase 1/Phase 2
Completed NCT01215292 - ITT4 Intratesticular Hormonal Milieu in Man (ITT4) Phase 1/Phase 2
Completed NCT00782392 - Bioavailability and Dosing of a Monosaccharide Supplement in Adults N/A
Completed NCT03714685 - Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations Phase 1
Completed NCT05277597 - Effect of a 4-week Post-exercise Sauna Bathing on Targeted Gut Microbiota N/A
Completed NCT01032616 - Uptake and Utilization of Amino Acids by Splanchnic Bed Phase 1
Completed NCT01830335 - Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Environmental Stress Phase 4
Completed NCT00902512 - Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations Phase 4
Completed NCT00475371 - A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males Phase 1
Completed NCT01870102 - Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects Phase 1